CME in Minutes: Education in Primary Care
By Answers in CME
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Answers in CME
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 228
Description
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Primary Care by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for the busy primary care providers to cover the diagnosis, treatment, follow-up, and clinical management of various disease states. Earning your CME/CE credit has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.
| Episode | Date |
|---|---|
|
Taofeek K. Owonikoko, MD, PhD, MS / Ticiana Leal, MD - New Frontiers in Small Cell Lung Cancer: Getting Ready for the Emergence of B7-H3–Directed ADCs
|
Dec 12, 2025 |
|
Nicola Hanania, MD, MS / Surya P. Bhatt, MD, MSPH - Demystifying the Evidence for Biologics in COPD: Strategies for Optimized, Patient-Centered Management
|
Dec 11, 2025 |
|
Sheilagh M. Maguiness, MD, FAAP / Elizabeth Vainder, MD, FAAP - Escalating Atopic Dermatitis Treatment in Pediatric Patients With Confidence: What Do the Guidelines Tell Us?
|
Dec 10, 2025 |
|
Tina Bhutani, MD, MAS, FAAD / Robin K. Dore, MD - The Dermatology-Rheumatology Psoriatic Playbook: Advancing Care With Novel Oral Therapies in the Evolving PsA Landscape
|
Dec 09, 2025 |
|
Stella Lee, MD / Kathleen Buchheit, MD - Striving for Patient Satisfaction in the Present and Future: Personalizing Treatment in an Evolving Paradigm
|
Dec 08, 2025 |
|
Charu Aggarwal, MD, MPH / Benjamin Levy, MD, FASCO - Rapid Roundup in NSCLC: Keeping Up with ADC Therapies Driving Precision Lung Cancer Care
|
Dec 05, 2025 |
|
April W. Armstrong, MD, MPH / Linda Stein Gold, MD / Clive M. Liu, MD - Personalizing Psoriasis Care Across the Map: Navigating Regional Barriers to Integrating Oral Small Molecule Treatment for Moderate to Severe Disease
|
Dec 03, 2025 |
|
Michael Postow, MD - Enhancing First-Line Treatment Selection in Advanced Melanoma: A Patient-Centered Approach
|
Dec 02, 2025 |
|
Mark Awad, MD, PhD / Carl M. Gay, MD, PhD - Breaking News in Small-Cell Lung Cancer: Expert Insights on B7-H3–Directed Antibody–Drug Conjugates From Recent Congresses
|
Dec 01, 2025 |
|
Wells A. Messersmith, MD - Illustrating the Journey to Improved Outcomes for MSI-H/dMMR Metastatic CRC: Bringing Immunotherapy-Based Regimens to the Forefront
|
Nov 28, 2025 |
|
Stella Lee, MD / Joseph K. Han, MD, FARS, FAAAAI - Spotlight on Emerging Biologics: Interpreting the Latest Efficacy and Safety Signals
|
Nov 27, 2025 |
|
Caron Jacobson, MD - Where Do Antibody–Drug Conjugates Fit in Relapsed/Refractory Diffuse Large B-Cell Lymphoma? Addressing Community Questions and Real-World Approaches to Selecting and Sequencing Novel Therapies
|
Nov 25, 2025 |
|
Luis Paz-Ares, MD, PhD / Lauren Averett Byers, MD - Shaping the Future of SCLC Treatment: Advancing Care Through Innovative Approaches
|
Nov 24, 2025 |
|
Seenu M. Hariprasad, MD - A Closer Look at Emerging Anti-VEGF Therapies in Retinal Vein Occlusion Management: Practical Guidance for Specialists
|
Nov 21, 2025 |
|
Doreen Addrizzo-Harris, MD - Relieving the Weight of Non-Cystic Fibrosis Bronchiectasis: Updated Strategies for an Evolving Landscape
|
Nov 20, 2025 |
|
Terry Faleye, MPAS, PA-C / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Beyond Biologics for Psoriasis and PsA: TYK2 Inhibitors and Practical Considerations for Personalizing Care
|
Nov 19, 2025 |
|
Arielle Elkrief, MD - Navigating Neoadjuvant, Adjuvant, and Perioperative Immunotherapy in Resectable High-Risk Melanoma: Tailoring Care for Optimal Outcomes
|
Nov 18, 2025 |
|
Stella Lee, MD / Kathleen Buchheit, MD - Advances in CRSwNP: Rethinking Biologics and Inflammation at the Source
|
Nov 18, 2025 |
|
Manjot K. Gill, MD, MS, Steven Ferrucci, OD, FAAO - Driving Diagnosis and Navigating the Role of Anti-VEGF Therapies in Managing Retinal Vein Occlusion
|
Nov 13, 2025 |
|
Linda Stein Gold, MD / April W. Armstrong, MD, MPH / Erin Boh, MD, PhD - Personalizing Psoriasis Care Across the Map: Navigating Regional Barriers to Integrating Oral Small Molecule Treatment for Moderate to Severe Disease
|
Nov 07, 2025 |
|
Asim V. Farooq, MD, Erica L. Mayer, MD, MPH - Ocular Safety in Breast Cancer Care: What Eye Clinicians Need to Know About Novel Oral Endocrine Therapies
|
Nov 06, 2025 |
|
Edward B. Garon, MD, MS - A Case of Best Practices: Optimizing First-Line Chemoimmunotherapy for Advanced Squamous NSCLC
|
Nov 03, 2025 |
|
Yasha Modi, MD - Putting Evidence Into Practice: Case-Based Strategies for Long-Acting Anti-VEGF Agents in nAMD
|
Oct 31, 2025 |
|
Luis Paz-Ares, MD, PhD / Kristin Higgins, MD - Creating a Roadmap to Optimize Care for Patients With LS-SCLC: Integrating the Evidence Into Practical Care
|
Oct 30, 2025 |
|
Charles L. Daley, MD / David E. Griffith, MD - Staying on Track with MAC Lung Disease Care: From Accurate Diagnosis to Evolving Management Strategies
|
Oct 28, 2025 |
|
MeiLan Han, MD, MS / Eddie Needham, MD, FAAFP / Valerie Chang - COPD Primary Care Playbook: Boosting Diagnosis, Treatment, and Therapy Escalation for Optimal Disease Control
|
Oct 17, 2025 |
|
Jerry P. Abraham, MD MPH CMQ / Chuck Vega, MD- Primary Care Immunization Showdown: What Would You Do in These Complex Vaccine Scenarios?
|
Oct 15, 2025 |
|
Andrew M. Brunner, MD - FLT3 Inhibitors in Action: Clinical Case Challenges in Newly Diagnosed AML
|
Oct 03, 2025 |
|
Lisa Larkin, MD, FACP, MSCP, IF - Advancing Menopause Management: Integrating Neurokinin-Targeted Therapies for Vasomotor Symptoms
|
Oct 01, 2025 |
|
Alice YY Cheng, MD, FRCPC / Jill Trinacty, MD, FRCPC, ABOM / Bruce A. Perkins, MD, MPH - From Daily to Weekly: Advancing the Basal Insulin Landscape for Type 2 Diabetes
|
Sep 30, 2025 |
|
Kathleen Moore, MD, MS, FASCO, Debra Richardson, MD - Current and Future Treatment of Platinum-Resistant Ovarian Cancer With ADCs: Implications of Targeting CDH6
|
Sep 30, 2025 |
|
Ramez N. Eskander, MD - Selecting the Optimal Regimen for Advanced Endometrial Cancer: A Case-Based, Multidisciplinary Approach
|
Sep 30, 2025 |
|
Ticiana Leal, MD / Neal Ready, MD, PhD - From Cases to Care: Personalizing First-Line Immunotherapy in Advanced NSCLC Through a Patient-Centered Approach
|
Sep 24, 2025 |
|
Vlad Ratziu, MD, PhD - Bridging Disciplines to Advance Care in MASH: Exploring GLP-1 RAs for Obesity-Related Liver Disease
|
Sep 24, 2025 |
|
Christine Franzese, MD / Eileen Wang, MD, MPH - From Case to Clinic: Personalizing the Use of Biologics in CRSwNP Care Plans
|
Sep 22, 2025 |
|
Raffaele Califano, MD / Nicolas Girard, MD, PhD / Antonio Passaro, MD, PhD - Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes
|
Sep 10, 2025 |
|
Tina Q. Tan, MD / Litjen (L.J) Tan, MS, PhD - Empowering Patients, Strengthening Immunity: Strategies to Increase Influenza Vaccination Across All Age Groups
|
Sep 09, 2025 |
|
Priya Vakharia, MD - The Long View in Neovascular Age-Related Macular Degeneration: Practical Insights on Long-Acting Anti-VEGF Treatment
|
Sep 03, 2025 |
|
Scott Solomon, MD - Mapping the Future of Heart Failure Care: The Evolving Role of Nonsteroidal MRAs in the Treatment of Patients With Heart Failure and Mildly Reduced/Preserved Ejection Fraction
|
Sep 01, 2025 |
|
Jesus Berdeja, MD - Chartering New Frontiers in Myeloma Care: What Role May Novel CELMoDs Play in Early-Relapse Therapy?
|
Aug 18, 2025 |
|
April W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Next-Generation Treatments for Moderate-to-Severe Plaque Psoriasis: What's New in TYK2
|
Aug 04, 2025 |
|
Daniel Petrylak, MD - Answering Key Questions About Biomarkers in Urothelial Cancer: Guidance for Improving Implementation
|
Jul 31, 2025 |
|
Fernando Jose Martinez, MD, MS, Justin Oldham, MD, MS - Advancing Patient-Centered ILD Care: Post-Congress Insights on Antifibrotics, Treatment Innovations, and Multidisciplinary Approaches
|
Jul 29, 2025 |
|
Luis Paz-Ares, MD, PhD / Niels Reinmuth, MD, PhD - Developing a Master Plan for ES-SCLC: A Practical Guide to Elevate Care in the Real-World
|
Jul 28, 2025 |
|
John Marshall, MD - Re-Invigorating the Later-Line Treatment of Metastatic Colorectal Cancer: Practical Strategies to Optimize the Use of Tyrosine Kinase Inhibitors
|
Jul 18, 2025 |
|
Neil D. Gross, MD, FACS - Evolving the Multi-Modal Approach for Resectable Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Assessment of Current and Emerging Immunotherapeutic Strategies
|
Jul 11, 2025 |
|
Hussein Tawbi, MD, PhD - Evolving Melanoma Care: The Clinical Impact of Anti-LAG-3/PD-1 Combinations
|
Jul 07, 2025 |
|
Evan S. Dellon, MD, MPH - Stepping Up the Management of Eosinophilic Esophagitis: Answering Key Questions on Diagnosis and Use of Pharmacotherapies
|
Jul 04, 2025 |
|
Thomas Powles, MBBS, MRCP, MD / Jonathan E. Rosenberg, MD - Advancing Urothelial Carcinoma Care With Multidisciplinary Strategies for Clinical Management
|
Jul 03, 2025 |
|
Barbara Burtness, MD - The Pan-Tumor Perspective: Looking Toward the Future of Care With HER3-Directed ADCs for Pretreated Patients With Advanced Solid Tumors
|
Jul 01, 2025 |
|
James F. Howard Jr., MD - C5 Inhibitors for the Treatment of Generalized Myasthenia Gravis: From Clinical Data to Patient-Centered Strategies
|
Jun 26, 2025 |
|
Mark A. Socinski, MD - Global Perspectives on Biomarker Testing in NSCLC: Clinical Insights on Optimizing Implementation in Practice
|
Jun 24, 2025 |
|
Venkataraman Raman Muthusamy, MD, MAS - A Window of Opportunity: Identifying the Risk of Esophageal Adenocarcinoma With Prognostic Testing
|
Jun 23, 2025 |
|
Nicholas J. Silvestri, MD - Transforming Outcomes for Patients With gMG Through Enhanced Disease Control: A Focus on FcRn Antagonists
|
Jun 12, 2025 |
|
Aditya Bardia, MD / Sara Hurvitz, MD - Making a World of Difference for Patients With HER2-Low and -Ultralow Advanced Breast Cancer: Practical Strategies to Integrate Antibody-Drug Conjugates in Special Populations
|
Apr 16, 2025 |
|
Elizabeth A. Thiele, MD, PhD - Enhancing Diagnosis and Long-Term Care of Patients With Lennox-Gastaut Syndrome: A Case-Based Approach to Optimizing Treatment Strategies
|
Apr 14, 2025 |
|
Komal Jhaveri, MD, FACP - Opportunities to Personalize Care: Making the Case for TROP2-Directed ADCs in HR+, HER2- Metastatic Breast Cancer
|
Apr 10, 2025 |
|
Aditya Bardia, MD / Sara Hurvitz, MD - Realizing the Potential of Antibody-Drug Conjugates in HER2-Low and -Ultralow Advanced Breast Cancer: Evolving Strategies to Individualize Care
|
Apr 10, 2025 |
|
David E. Griffith, MD - Guiding Principles in the Management of Refractory Mycobacterium Avium Complex (MAC) Pulmonary Disease: Casing the Evidence to Inform Practical Care
|
Apr 07, 2025 |
|
Aditya Bardia, MD / Marilyn M. Bui, MD, PhD - Bringing HER2 Low and Ultralow to Light: How to Define and Detect HER2 Status in Advanced Breast Cancer
|
Apr 04, 2025 |
|
Nathan Falk, MD, MBA, FAAFP - Making Sense of Type 2 Inflammation Crosstalk in Chronic Diseases: Perspectives on Improving Emergency and Primary Care Collaboration
|
Apr 02, 2025 |
|
Thomas Martin, MD - Focusing on the Frontline: The Impact of Anti-CD38-Based Quadruplet Regimens for Transplant-Ineligible, Newly-Diagnosed Myeloma
|
Mar 07, 2025 |
|
James E. Galvin, MD, MPH - Voyage Through AD: From Early Detection to Collaborative Care
|
Feb 17, 2025 |
|
Paul Gissen, MD, PhD - A Journey Through Metachromatic Leukodystrophy: From Diagnosis to Clinical Care
|
Feb 05, 2025 |
|
Arvind Dasari, MD - Leveling Up Care in the Later-Line Treatment of Metastatic Colorectal Cancer: Bringing Quality of Life to the Forefront
|
Jan 31, 2025 |
|
Joshua Richter, MD, FACP - Enhancing Outcomes in Heavily Pretreated Relapsed/Refractory Multiple Myeloma: Harnessing Bispecific Antibodies in Community Care
|
Jan 08, 2025 |
|
Jai Radhakrishnan, MD, MS - IgA Nephropathy in Focus: Novel Treatment Strategies for Nephrologists and PCPs
|
Jan 03, 2025 |
|
Scott MacDiarmid, MD - Streamlining Patient Flow: A Clinician’s Guide to Optimizing the Use of Beta-3 Adrenergic Agonists for Overactive Bladder Management
|
Jan 02, 2025 |
|
Arzu Yorgancioglu, MD - A Global Approach to Asthma Management: Examining Biologics
|
Jan 02, 2025 |
|
Claus Bachert, MD, PhD / Cecelia Damask, DO - Managing CRSwNP With Biologic Therapies: A Global Dialogue
|
Dec 20, 2024 |
|
Sunandana Chandra, MD, MS - Practical Guidance on Managing Adverse Events Associated With Immunotherapy Regimens for Nonmelanoma Skin Cancers
|
Dec 17, 2024 |
|
Alexander I. Spira, MD, PhD, FACP - Biomarkers at the Forefront: The Crucial Role of Testing Across Solid Tumor Types
|
Dec 13, 2024 |
|
David Harpole, MD / Alfredo Addeo, MD - The Possibilities of Perioperative: Assessing the Use of Perioperative Immunotherapy for Resectable NSCLC
|
Dec 12, 2024 |
|
Megan Huchko, MD, MPH - Isn't HPV Vaccination Only for Pre-Teens? Answering the Why and How of Adult Vaccination
|
Dec 06, 2024 |
|
Jacob Sands, MD / Luis Paz-Ares, MD, PhD - Advancing Care in EGFR-Mutated NSCLC: Unveiling New Horizons With ADCs
|
Dec 02, 2024 |
|
Erin Barrett (Wei), MD - Focusing on the Patient to Enhance Therapeutic Care: Advancing Early Diagnosis and Management of Bullous Pemphigoid
|
Nov 29, 2024 |
|
Csaba P. Kovesdy, MD - Integrating Nonsteroidal MRAs in Practice: A Guideline-Driven Approach to the Management of CKD and T2D
|
Nov 29, 2024 |
|
Shawn Kwatra, MD - Itching to Reduce the Burden of Prurigo Nodularis: The Latest Evidence and Strategies for Optimizing Biologic Therapy
|
Nov 29, 2024 |
|
David S. Boyer, MD / Irving Posalski, MD - PCP-Specialists Share a Lens to Magnify Outcomes With VEGF-Targeting Agents for DME
|
Nov 26, 2024 |
|
David Harpole, MD / Neel Chudgar, MD - The Practicalities of Perioperative Immunotherapy for Resectable NSCLC
|
Nov 26, 2024 |
|
René S. Kahn, MD, PhD - Elevating the Patient Voice in Bipolar I Disorder Management: A Collaborative Approach to Shared Decision-Making
|
Nov 26, 2024 |
|
David Harpole, MD / Nicolas Girard, MD, PhD - Trials and Tribulations: Examining the Data for Perioperative Immunotherapeutic Approaches in Resectable NSCLC
|
Nov 20, 2024 |
|
Jacob Sands, MD / Luis Paz-Ares, MD, PhD - Leveraging Precise Targets to Elevate Outcomes: NSCLC Treatment Strategies for HER2-Directed ADCs
|
Nov 15, 2024 |
|
Jia Ruan, MD, PhD - Clinical Case Challenges in Frontline PTCL: Navigating the Landscape of CD30-Positive PTCL Treatment
|
Nov 15, 2024 |
|
Evan S. Dellon, MD, MPH - In Case of Emergency: Ensuring Timely Recognition and Intervention in Patients With Eosinophilic Esophagitis
|
Nov 06, 2024 |
|
Christoph U. Correll, MD - Transforming the Treatment of Schizophrenia: Moving Beyond Anti-Dopaminergic Antipsychotics to Muscarinic Receptor Agonists
|
Nov 06, 2024 |
|
Nikhil I. Khushalani, MD - Practical Guidance for Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: Using Immunotherapy Effectively in Clinical Practice
|
Nov 06, 2024 |
|
Jacob Sands, MD / Raffaele Califano, MD - Novel ADC Targets in Advanced NSCLC: Examining Emerging Strategies for TROP2-Directed ADCs
|
Oct 30, 2024 |
|
Juliana M. Kling, MD, MPH - Turning Down the Heat: Exploring Newly Approved and Emerging Nonhormonal Therapies for Menopause-Associated VMS
|
Oct 07, 2024 |
|
Christoph U. Correll, MD - Pathways to Hope: Emerging Therapies in Alzheimer’s Disease Psychosis
|
Sep 27, 2024 |
|
Stephanie A. Christenson, MD, MAS - Targeting Eosinophils for Fewer Exacerbations: The Future of Biologic Treatments in COPD Management
|
Sep 20, 2024 |
|
Joyce O'Shaughnessy, MD - Harnessing Immunotherapy for Early Breast Cancer Management: Neoadjuvant Updates in HR-Positive, HER2-Negative Disease
|
Sep 20, 2024 |
|
Ahmad Tarhini, MD, PhD - Adjuvant Approaches in High-Risk, Resectable Melanoma: A Practical Guide to Improving Outcomes With Immunotherapy-Based Regimens
|
Sep 19, 2024 |
|
David M. Miller, MD, PhD / Todd Schlesinger, MD - A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies
|
Sep 13, 2024 |
|
Mark Awad, MD, PhD - Advancing the Therapeutic Landscape of SCLC with B7-H3–Targeted Antibody-Drug Conjugates: Insights and Future Directions
|
Sep 09, 2024 |
|
Leonard B. Bacharier, MD - Highlighting the Use of Biologics in Pediatric Patients: Case Scenarios to Elevate Asthma Treatment
|
Sep 09, 2024 |
|
Vasu Divi, MD, MS - Neoadjuvant Immunotherapy for CSCC: Practical Considerations for Resectability, Patient Selection, and Treatment Optimization
|
Sep 09, 2024 |
|
Vibeke Strand, MD / April W. Armstrong, MD, MPH - A New Take on TYK2 Inhibitors: Bridging Gaps in Psoriatic Arthritis Management With Novel Targeted Therapies
|
Sep 04, 2024 |
|
Cecelia Damask, DO - Evidence-Based Approaches to Sequencing and Switching Biologic Therapies in Patients With CRSwNP and Comorbidities
|
Aug 16, 2024 |
|
Aditya Bardia, MD - From Theory to Practice: Enhancing Antibody-Drug Conjugate Integration in HER2-Low Advanced Breast Cancer
|
Aug 09, 2024 |
|
Eileen Wang, MD, MPH - Breathing Life Into Type 2 Asthma: Advancing Clinical Remission With Biologics
|
Aug 05, 2024 |
|
Stephanie E. Combs, MD / Heather Wakelee, MD - A Growing Need for Targeted Approaches in Unresectable Stage III NSCLC: A Clinical Evaluation of Evolving Data in EGFR Mutation–Positive Disease
|
Aug 05, 2024 |
|
Rami Komrokji, MD - Navigating the First-Line Treatment Landscape of Anemia in Lower-Risk MDS: Translating the Latest Data to Practice
|
Aug 05, 2024 |
|
Chris Verslype, MD, PhD - Optimizing TKI Therapy for Individualized Advanced HCC Treatment: Taking a Real-World Perspective
|
Jul 12, 2024 |
|
Luis Paz-Ares, MD, PhD - Exploring the Potential of TROP2 ADCs for Advanced/Metastatic NSCLC: Implications for Practice
|
Jul 12, 2024 |
|
Ticiana Leal, MD - Squaring Off With Squamous NSCLC: The Latest Evidence and Guidance on Chemoimmunotherapy Options
|
Jul 04, 2024 |
|
Ghassan Abou-Alfa, MD, MBA - Getting On the Right Tract: Patient-Centered Strategies to Diagnose Biliary Tract Cancers
|
Jul 04, 2024 |
|
Jonathan Silverberg, MD, PhD, MPH - Taking a Hands-On Approach to the Management of Moderate to Severe Hand and Foot Atopic Dermatitis: Enhancing Patient Outcomes With Novel Systemic Therapies
|
Jul 04, 2024 |
|
Sagar Lonial, MD, FACP - Accelerating Targeted Degradation in Multiple Myeloma: The Role of CELMoDs in Overcoming IMiD Resistance in Earlier Lines of Therapy
|
Jul 04, 2024 |
|
Ben Carpenter, MD, PhD - Exploring Novel Therapeutic Frontiers in Transfusion-Dependent Beta Thalassemia: The Path to Transfusion Independence
|
Jun 25, 2024 |
|
Saad Z. Usmani, MD, MBA, FACP, FASCO - Making the Case for Triple Therapy in R/R Multiple Myeloma: Expert Guidance for Optimizing Anti-CD38 mAb Regimens
|
Jun 25, 2024 |
|
Michael Thorpy, MD - Narcolepsy and Cardiovascular Health: Real-World Strategies to Enhance Long-Term Patient Outcomes
|
Jun 25, 2024 |
|
Josep M. Llovet, MD, PhD - Redefining How to Treat Intermediate-Stage HCC: Exploring TACE Plus Immunotherapy–Based Combination Therapy
|
Jun 18, 2024 |
|
Richard Bernstein, MD, PhD - Factoring a Balanced Efficacy and Safety Profile Into the Equation: Exploring FXIa Inhibitors in Stroke Prevention
|
Jun 18, 2024 |
|
Richard Kim, MD - Enhancing Treatment Sequencing to Extend Survival: Tailoring Later-Line Care to the Patient With Metastatic Colorectal Cancer
|
May 28, 2024 |
|
Joseph Domachowske, MD - From Guidelines to Practice: The Latest Strategies for RSV Prevention in Infants
|
May 15, 2024 |
|
Nick H. Kim, MD - Multimodal Management of Inoperable CTEPH: Evolving Therapeutic Strategies
|
May 15, 2024 |
|
Jyoti Mayadev, MD - From Routine Screening to Applying Clinical Advances in Locally Advanced Cervical Cancer: Evolving Care in High-Risk Populations
|
Apr 30, 2024 |
|
M. Scott Perry, MD - Easing the Diagnostic Journey for Both Children and Adults With Lennox-Gastaut Syndrome: Patient-Centered Strategies
|
Apr 05, 2024 |
|
Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician
|
Apr 05, 2024 |
|
Peter Lio, MD - Generative AI: Benefits for Your Practice, for Your Patients
|
Apr 05, 2024 |
|
Geoffrey Ku, MD, MBA - Conversations in Precision Oncology: Harnessing Testing to Drive Personalized Treatment in HER2-Positive Advanced Gastric Cancer
|
Apr 05, 2024 |
|
Martin C. Mahoney, MD, PhD - Reducing the Burden of HPV-Related Cancers: Strategies for Improving HPV Vaccine Uptake in Males
|
Mar 29, 2024 |
|
Iacopo Olivotto, MD - A New Chapter in Hypertrophic Cardiomyopathy Management: Updates From the European Society of Cardiology (ESC) 2023 Guidelines and New Treatment Options
|
Mar 25, 2024 |
|
Laura Spring, MD - The Patient-Clinician Alliance to Enhance Care for Patients With Metastatic Breast Cancer on Antibody-Drug Conjugates
|
Mar 25, 2024 |
|
Heather Wakelee, MD - Stepping Up Clinical Outcomes for Resectable NSCLC: Examining the Role of Neoadjuvant Plus Adjuvant Immunotherapy Regimens
|
Mar 14, 2024 |
|
Sue S. Yom, MD, PhD - Latest Updates in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Clinical Potential of Inhibitor of Apoptosis Protein (IAP) Antagonists to Change the Treatment Landscape
|
Mar 08, 2024 |
|
Steven M. Horwitz, MD - Advancing The Treatment Paradigm in Relapsed/Refractory B- and T-Cell Lymphoma: The Evolving Role of EZH1/2 Pathway Inhibitors
|
Mar 06, 2024 |
|
Juliana M. Kling, MD, MPH - Improving Inclusive Care: Enhancing HPV Vaccine Uptake Among LGBTQ+ Individuals
|
Feb 28, 2024 |
|
Nikhil I. Khushalani, MD - Pointing the Way to Enhanced Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Practical Strategies to Incorporate Neoadjuvant Immunotherapy
|
Feb 26, 2024 |
|
Stephen M. Ansell, MD, PhD / Caron Jacobson, MD, MMSc - Navigating a New Treatment Algorithm for Patients With Relapsed/Refractory Follicular Lymphoma: Where Do CD20 x CD3 Bispecific Antibodies Fit In?
|
Feb 26, 2024 |
|
Susana M. Campos, MD, MPH - Expanding the Potential of HER2-Directed Antibody-Drug Conjugates: Evidence and Application in New Tumor Types
|
Feb 22, 2024 |
|
Stephanie Sacharow, MD - Empowering Patients with Phenylketonuria: Effective Communication Strategies for Improved Care
|
Feb 22, 2024 |
|
John N. Allan, MD - Enhancing Patient Outcomes in Relapsed/Refractory Follicular Lymphoma: Recognizing the Role of Novel Bispecific Antibody–Based Therapies
|
Feb 14, 2024 |
|
Jonathan Barker, BSc, MB, BS, MD, FRCP - Novel Approved and Emerging IL-36 Receptor Inhibitors for the Treatment of GPP
|
Jan 26, 2024 |
|
Nicola A. Hanania, MD, MS - Enough: Targeting Eosinophilic Pathways With Biologics in Chronic Obstructive Pulmonary Disease
|
Jan 12, 2024 |
|
Peter R. Galle, MD, PhD - Assembling a Long-Term Sequential Plan for Unresectable HCC: Practical Guidance for Improving Real-World Outcomes
|
Jan 10, 2024 |
|
David M. Miller, MD, PhD / Kevin Emerick, MD - Coming Together to Improve Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Multidisciplinary Care Strategies With Neoadjuvant Immunotherapy
|
Jan 03, 2024 |
|
Tanya Siddiqi, MD - Addressing Patient Needs With CAR T-Cell Therapy in the Treatment of CLL/SLL: Preparing for an Evolving Treatment Paradigm
|
Jan 03, 2024 |
|
Kristina M. Deligiannidis, MD - Tailoring Treatment Plans in Postpartum Depression: Integrating Novel Agents Into Clinical Practice for Personalized Care
|
Jan 03, 2024 |
|
Diana V. Do, MD - An Eye Toward Improving the Management of DME: Diagnosis and Shared Decision-Making
|
Dec 29, 2023 |
|
Manish A. Shah, MD - Keeping Current on Frontline Immunotherapy-Chemotherapy Combinations: HER2-Positive and HER2-Negative Unresectable Advanced Gastric or GEJ Adenocarcinoma
|
Dec 29, 2023 |
|
Josep M. Llovet, MD, PhD - Enhancing Long-Term Survival in Unresectable HCC: Optimizing First-Line Immunotherapy-Based Combination Regimens
|
Dec 18, 2023 |
|
Vishal A. Patel, MD - Making Headway in Treating Resectable Cutaneous Squamous Cell Carcinoma: Setting Sights on Neoadjuvant Immunotherapy
|
Dec 18, 2023 |
|
Adam Brufsky, MD, PhD - Getting Real With Patients During Clinical Decision-Making: The Value of Sharing Real-World Evidence About CDK4/6 Inhibitors for HR+/HER2- Metastatic Breast Cancer
|
Dec 18, 2023 |
|
Wolfgang Miesbach, MD, PhD - Gene Therapy in Hemophilia A: Redefining the Treatment Paradigm
|
Dec 05, 2023 |
|
Jennifer Hill, MD - Breathing New Air Into Improved Outcomes: Strategies to Optimize Care in Patients With Uncontrolled Asthma
|
Dec 05, 2023 |
|
Talia Kaden, MD - Considerations for Identifying the Right Patient for Intravitreal Anti-VEGF Injections in nAMD
|
Nov 13, 2023 |
|
Asa Radix, MD, PhD, MPH - A Call to Action to Prevent Cervical Cancer in Transgender and Nonbinary Populations: Patient-Centered Strategies to Increase Screening Rates
|
Oct 31, 2023 |
|
Trisha Wise-Draper, MD, PhD - Empowering Precision Decisions: PD-1 Inhibitor-Based Therapies and Biomarker Testing in R/M HNSCC
|
Oct 11, 2023 |
|
Pam R. Taub, MD, FACC - Making the Case for Novel LDL-C–Lowering Therapies in the Management of Pediatric and Adult Homozygous Familial Hypercholesterolemia
|
Oct 09, 2023 |
|
Shawn Kwatra, MD - Itching for Relief: Exploring the Role of Novel Biologics in Prurigo Nodularis
|
Oct 06, 2023 |
|
Diana V. Do, MD / Michael A. Singer, MD - An Eye Toward Improving Outcomes in DME: Timely Diagnosis and Reduced Treatment Burden With Longer-Acting Anti-VEGF Agents
|
Oct 06, 2023 |
|
Richard Finn, MD - Improving Patient Outcomes in Advanced Biliary Tract Cancer: Evaluating the Promise of Immunotherapy Plus Chemotherapy Combinatorial Approaches
|
Sep 25, 2023 |
|
Sapna P. Patel, MD - Enhancing Neoadjuvant and Adjuvant Treatment in Resectable Melanoma: Is Timing the Key to Improved Outcomes?
|
Sep 19, 2023 |
|
Joshua Richter, MD / Saad Z. Usmani, MD, MBA, FACP - Optimizing Patient Outcomes in Relapsed/Refractory Multiple Myeloma: The Role of Novel BCMA-Targeted Bispecific Antibodies
|
Sep 19, 2023 |
|
Christopher P. Cannon, MD / Geetha Raghuveer, MD, MPH, MRCP - The Cholesterol Conversation: Early and Intensive Treatment of Homozygous Familial Hypercholesterolemia With Novel LDL-Lowering Strategies
|
Sep 19, 2023 |
|
Eric K. Singhi, MD / Charu Aggarwal, MD, MPH - It Takes Two to Tango: Exploring the Clinical Implications of First-Line Immunotherapy Plus Chemotherapy Combinations in Advanced NSCLC
|
Sep 05, 2023 |
|
Alexander I. Spira, MD, PhD, FACP - Breaking News in NSCLC: The Latest Evidence on Emerging Antibody Drug Conjugates Targeting TROP2
|
Sep 05, 2023 |
|
Jeffrey B. Geske, MD / Anjali Tiku Owens, MD - Expert Cardiology Perspectives in HCM: Slowing Disease Progression With Early Diagnosis and Integration of Cardiac Myosin Inhibitors
|
Aug 29, 2023 |
|
David S. Boyer, MD - An Eye Toward Improving Adherence: Easing the DME Treatment Burden With Longer-Acting Anti-VEGF Agents
|
Aug 23, 2023 |
|
Peter Lio, MD - Enriching Care for Pediatric Atopic Dermatitis: Evidence-Based Strategies for Integrating Targeted Systemic Therapies
|
Aug 23, 2023 |
|
Kieran McCafferty, MB BChir, MRCP, MDres - The Latest News on SGLT2 Inhibitors in Chronic Kidney Disease: Improving Outcomes With Early Intervention
|
Aug 23, 2023 |
|
Jamie E. Chaft, MD - Enhancing Outcomes for Patients With Resected, Early-Stage NSCLC: A Piercing Evaluation of the Clinical Support for Adjuvant Immunotherapies
|
Aug 23, 2023 |
|
Stephen Lam Chan, MD - Recalibrating Survival: Available and Recently Approved Immunotherapy-Based Combination Approaches in Unresectable HCC
|
Aug 17, 2023 |
|
W. Lloyd Clark, MD - The Urgency of Retinal Vein Occlusion: Timely Detection, Referral, and Management
|
Aug 17, 2023 |
|
Bradley Chipps, MD - Calling the Shots for Pediatric Asthma Control: Integrating Biologics Into the Treatment Plan to Enhance Outcomes
|
Aug 17, 2023 |
|
Yasha Modi, MD / Christina Y. Weng, MD, MBA - Weighing Out the Risks and Benefits of Intravitreal Anti-VEGF Injections for nAMD
|
Aug 07, 2023 |
|
Eric Jonasch, MD - Optimizing Long-Term Care With Guideline-Recommended Systemic Treatment Options for von Hippel-Lindau Disease-Associated Renal Cell Carcinoma
|
Jul 27, 2023 |
|
Saad Z. Usmani, MD, MBA, FACP / Gareth J. Morgan, MD, PhD - Strength in Numbers: Triplet Combination Therapies in Relapsed/Refractory Multiple Myeloma (RRMM) Special Patient Populations
|
Jul 07, 2023 |
|
Christoph U. Correll, MD - Empowering Patients With Bipolar I Disorder: The Role of Atypical Antipsychotics for Acute Treatment of Manic or Mixed Episodes and Maintenance Therapy
|
Jul 04, 2023 |
|
April W. Armstrong, MD, MPH - Looking Ahead: What the Future Holds for Novel Systemic Therapies in the Treatment of Moderate-to-Severe Atopic Hand and Foot Dermatitis
|
Jul 03, 2023 |
|
Miguel-Angel Perales, MD - Shifting Gears in Treating Relapsed and Refractory Indolent B-Cell Lymphomas: Where Do CAR T Cell Therapies Stand in FL and CLL/SLL?
|
Jul 03, 2023 |
|
Tina Q. Tan, MD - Easing the RSV Burden in Infants: Looking Ahead to New Prevention Strategies
|
Jun 27, 2023 |
|
Tanios Bekaii-Saab, MD / Kelley A. Rone, DNP, AGNP-c - Providing Holistic Care for Hand-Foot Skin Reaction to Improve Outcomes for Patients on Multikinase Inhibitor Therapy for CRC
|
Jun 27, 2023 |
|
Gary W. Falk, MD, MS / Ikuo Hirano, MD - Enhancing Outcomes in Adults and Children With Eosinophilic Esophagitis by Targeting Type 2 Inflammation
|
Jun 08, 2023 |
|
Joseph Mikhael, MD, MEd, FRCPC / Paul G. Richardson, MD - Window of Opportunity in Relapsed/Refractory Multiple Myeloma: Is There an Earlier Role for Cereblon (CRBN) E3 Ligase Modulators to Improve Patient Outcomes?
|
May 31, 2023 |
|
Jonathan Schoenfeld, MD, MPH - Evolving the Treatment Landscape in Head and Neck Squamous Cell Carcinoma: Promoting Apoptosis With Emerging Antagonists of Inhibitors of Apoptosis Proteins
|
May 31, 2023 |
|
Russell D. Cohen, MD, FACG, AGAF - Changing the Course of Ulcerative Colitis: Addressing Unmet Needs Through Effective Disease Severity Assessments and New Therapeutic Strategies
|
May 30, 2023 |
|
John O. Mascarenhas, MD - Optimizing JAK Inhibitor Therapy for Patients With Myelofibrosis: Integrating New and Emerging Therapies Into the Current Treatment Paradigm
|
May 04, 2023 |
|
Jacqueline A. Nicholas, MD, MPH - Setting the Stage for Bruton’s Tyrosine Kinase Inhibitors in Relapsing Multiple Sclerosis: Where Does the Evidence Stand?
|
May 04, 2023 |
|
Sergio Giralt, MD, FACP, FASTCT - Charting a New Course in the Treatment Paradigm of Relapsed/Refractory Multiple Myeloma: The Current Snapshot of Novel CAR T-Cell Therapies
|
Apr 21, 2023 |
|
Tobias Welte, MD - Lowering the Risk of Respiratory Syncytial Virus in Older Adults: Late-Stage Emerging Vaccines
|
Apr 12, 2023 |
|
Kamala P. Tamirisa, MD, FACC, FHRS - Striving Toward Health Equity in Cardiovascular Disease: Patient-Centered Conversations to Address Social Determinants of Health in Nonvalvular Atrial Fibrillation
|
Apr 10, 2023 |
|
Murat Akova, MD / Jeffrey V. Lazarus, PhD, MIH, MA - Region-Specific, Patient-Centered Strategies for Optimizing Uptake of mRNA-Based COVID-19 Vaccination
|
Apr 10, 2023 |
|
Christine E. Jones, BMBS, PhD - A Full-Throated Appeal to Personalize Care in Advanced Gastroesophageal Junction (GEJ) and Esophageal Cancers: Where Do Immunotherapy-Based Regimens Fit In?
|
Apr 10, 2023 |
|
Pantelis Sarafidis, MD, MSc, PhD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists Early in the Course of Disease: Practical Strategies for Patients With Early-Stage CKD and T2D
|
Mar 30, 2023 |
|
Giovanni L. Ceresoli - Advancing Care in Advanced Non–Small-Cell Lung Cancer With Combination Locoregional and Systemic Therapies
|
Mar 30, 2023 |
|
George L. Bakris, MD, MA / Paul P. Doghramji, MD, FAAFP - Enhancing Patient Outcomes in CKD: Recognizing the Importance of Early Detection and Optimized Management
|
Mar 27, 2023 |
|
Christine E. Jones, BMBS, PhD - Preventing Congenital Cytomegalovirus Through Behavioral and Emerging Vaccination Strategies
|
Mar 27, 2023 |
|
Brian S. Kim, MD - Scratching the Itch: Biologic Breakthroughs in Prurigo Nodularis
|
Mar 16, 2023 |
|
Bruce E. Strober, MD, PhD - Patient Conversations in Plaque Psoriasis: Discussing Novel TYK2 Inhibitors for the Treatment of Patients Who Are Candidates for Systemic Therapy
|
Mar 16, 2023 |
|
Richard Finn, MD - Real Talk About CDK4/6 Inhibitors in the Treatment of HR+/HER2- Advanced Breast Cancer: Using Real-World Evidence to Impact Patient Outcomes
|
Feb 15, 2023 |
|
George Oral Waring IV, MD, FACS - Up Close With Presbyopia: Novel Emerging Miotic Agents for Aging Eyes
|
Jan 16, 2023 |
|
Marc E. Rothenberg, MD, PhD - Closing In on Improved Quality of Life for Patients With Eosinophilic Esophagitis by Targeting Type 2 Inflammation
|
Jan 09, 2023 |
|
Charles Pritchard, MD, FACR, RhMSUS - Bringing Emerging Therapies Into Motion for Non-Radiographic Axial Spondyloarthritis
|
Jan 04, 2023 |
|
Ellen J Scherl, MD - High Hopes for Emerging Small Molecules: Looking Ahead to Expanded Treatment Options for Moderate-to-Severe Crohn's Disease
|
Jan 04, 2023 |
|
Jennifer Green, MD - Integrating Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With CKD and T2D: Novel Strategies to Minimize Progression in Patients With Advanced Disease
|
Dec 29, 2022 |
|
Anne O'Donnell, MD - Diagnostic Imaging in Non-Cystic Fibrosis Bronchiectasis: The Radiologist's Role in Optimizing Care
|
Dec 29, 2022 |
|
Omid Hamid, MD - An Expert Conversation About Anti-LAG-3/PD-1 Combinations: Exploring the Clinical Impact of Approved and Emerging Combinations in the Advanced Melanoma Treatment Landscape
|
Dec 20, 2022 |
|
Christoph Wanner, MD - Bringing the Treatment of Patients With CKD and T2D up to Speed: Synthesizing Guideline Updates and the Latest Data for Non-Steroidal Mineralocorticoid Receptor Antagonists
|
Dec 13, 2022 |
|
Suriya Jeyapalan, MD, MPH - Improving Patient Outcomes in Newly Diagnosed Glioblastoma: A Focus on Novel Adjuvant Therapies
|
Dec 13, 2022 |
|
Theresa W. Guilbert, MD, MS - Blazing a Trail to Enhanced Outcomes for Children with Moderate-to-Severe Asthma: Practical Strategies to Incorporate Biologics
|
Dec 02, 2022 |
|
Seenu M. Hariprasad, MD - Talking About Treatment Failure in nAMD: Practical Strategies for Switching VEGF-Targeted Therapies
|
Dec 02, 2022 |
|
Matteo Bonini, MD, PhD - Maximizing Outcomes With Biologics: Gaining Control Over Uncontrolled Moderate-to-Severe Asthma in Children
|
Dec 02, 2022 |
|
Adam S. Wenick, MD, PhD - Keeping Sight of Adherence with VEGF-Targeted Therapy: Individualized Dosing Strategies to Improve Care for nAMD
|
Dec 02, 2022 |
|
Philip N Newsome, PhD, FRCPE - Incorporating Noninvasive Tools to Improve Diagnosis and Management of Nonalcoholic Steatohepatitis
|
Dec 02, 2022 |
|
Sandy Durrani, MD - Enhancing Control, Maximizing Outcomes: Advancements in Care for Children With Inadequately Controlled Asthma
|
Nov 28, 2022 |
|
Latanya Benjamin, MD, FAAD, FAAP - Improving the Care of Children with Moderate-to-Severe Atopic Dermatitis: When and How to Intensify Treatment with Novel Systemic Agents
|
Nov 16, 2022 |
|
Michael A. Singer, MD - Bringing Clarity to Patient Management in Diabetic Retinopathy and Diabetic Macular Edema: Practical Strategies to Integrate VEGF-Targeted Agents
|
Nov 15, 2022 |
|
Arndt Vogel, MD, PhD - Emerging Trends for Treating Advanced Biliary Tract Cancer: Where Does the Evidence Stand on Immunochemotherapy Combinations
|
Nov 07, 2022 |
|
Samuel L. Washington III, MD, MAS - Bridging the Gap in Prostate Cancer Outcomes for Black Men: Elevating Approaches to Androgen Deprivation Therapy
|
Nov 07, 2022 |
|
Ghassan Abou-Alfa, MD, MBA - Leveraging Combinatorial Approaches in Hepatocellular Carcinoma: An Exploration of the Clinical Implications of the Available Data
|
Oct 28, 2022 |
|
W. Lloyd Clark - A Close-Up on VEGF-Targeted Therapies in Diabetic Retinopathy and Diabetic Macular Edema
|
Oct 26, 2022 |
|
Scott Kahan, MD, MPH - Hurry Up and Weight: Making the Case for Early Intensification of Therapy in Patients With Type 2 Diabetes and Obesity
|
Oct 26, 2022 |
|
Javier Cortés, MD, PhD - BRCA Testing in Patients With Early-Stage Breast Cancer: A Focus on the Patient Conversation
|
Oct 24, 2022 |
|
Tanios Bekaii-Saab, MD / Beth McLellan, MD - Managing Hand-Foot Skin Reaction: Interdisciplinary Strategies for Patients on Multikinase Inhibitors
|
Oct 04, 2022 |
|
Sagar Lonial, MD - Rebooting the Treatment of Relapsed/Refractory Multiple Myeloma: A New Look at Novel Cereblon-Targeted Agents
|
Sep 30, 2022 |
|
Ikuo Hirano, MD - Closing In on Improved Quality of Life for Patients With Eosinophilic Esophagitis by Diagnosing Promptly and Understanding Type 2 Inflammation
|
Sep 26, 2022 |
|
Shalina Gupta-Burt, MD - Improving Patient Outcomes in Newly Diagnosed Glioblastoma: Personalizing Treatment and Managing Adverse Events
|
Sep 06, 2022 |
|
Orlando M. Gutierrez, MD - Reducing Disparities in Anemia of CKD Management
|
Sep 05, 2022 |
|
George Kassianos, CBE, MD (Hons), FRCGP - A Vaccinator’s Guide to Viral Vector–Based COVID-19 Vaccines
|
Sep 02, 2022 |
|
Nancy M. Holekamp, MD - Eyeing the Benefits and Risks of VEGF-Targeted Therapies for nAMD
|
Aug 31, 2022 |
|
Davey Smith, MD, MAS - At the Forefront of Therapy for COVID-19: Early Identification and Treatment of Outpatients at Higher Risk of Progression to Severe Illness
|
Aug 25, 2022 |
|
Christina Y. Weng, MD, MBA - A Window Into the Diabetic Eye: Strategies to Optimize the Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema
|
Aug 17, 2022 |
|
Jessica Ailani, MD - A Head Start on Acute and Preventive Migraine Treatment: Integrating the Latest Recommendations and Evidence on Oral CGRP-Targeted Therapies in Practice
|
Aug 09, 2022 |
|
Alexander Drilon, MD - Hitting the Mark in Personalizing Oncology Care: A Clinician’s Guide to Best Practices in Biomarker Testing
|
Aug 02, 2022 |
|
Diana V. Do, MD - Bringing Anti-VEGF Therapy into Focus: Comparing and Integrating Treatments for Retinal Vein Occlusion
|
Aug 02, 2022 |